My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$NKE {{ '2016-06-28T20:44:45+0000' | timeago}} • Infographic

$NKE Q4 2016 Earnings Infographic.

User Robert Smith {{ '2017-04-26T21:13:12+0000' | timeago}}

$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.

User Leroy John {{ '2017-04-26T21:11:32+0000' | timeago}}

$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.

User Irene Grennan {{ '2017-04-26T21:08:01+0000' | timeago}}

Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.

User Barbara Salley {{ '2017-04-26T17:50:03+0000' | timeago}}

Back with a bang! $TWTR

User Amelita Yates {{ '2017-04-26T17:23:10+0000' | timeago}}

Even though $TMUS is behind $VZ and $T, it is playing catchup in style! 1.1 million new subscribers in Q1!!

$BSX {{ '2017-04-27T11:12:47+0000' | timeago}} • Announcement

$BSX now estimates revenue for FY17 in a range of $8.8-8.9Bil (compared to prior guidance of $8.675-8.875Bil). Net income is expected between $0.81 and $0.86 per share (compared to prior guidance of $0.86-0.91 per share). Adjusted earnings outlook was reaffirmed at a range of $1.22-1.26 per share.

$BSX {{ '2017-04-27T11:08:18+0000' | timeago}} • Announcement

$BSX's sales in 1Q17 rose to $2.16Bil, helped by revenue growth in all segments. In a YoY basis, MedSurg revenue jumped 15%; Cardiovascular grew 8%; and Rhythm Management increased 7%.

$BSX {{ '2017-04-27T11:01:45+0000' | timeago}} • Announcement

Medical device maker $BSX reported 10% growth in revenue in 1Q17, which helped it post higher earnings. Net earnings were $290MM or $0.21 per share, compared to $202 million or $0.15 per share a year ago. On an adjusted basis, net earnings grew to $0.29 per share.

$IRM {{ '2017-04-27T10:50:20+0000' | timeago}} • Announcement

$IRM still expects 2017 revenue growth of 8-10% on constant dollar basis, to $3.75-3.84Bil, adjusted EBITDA growth of 16-19% to $1.25-1.28Bil and adjusted FFO growth of 8-15% to $715-760MM. The company still predicts adjusted EPS of $1.15-1.25, which reflects a 8-18% growth year-over-year.

$IRM {{ '2017-04-27T10:50:05+0000' | timeago}} • Announcement

$IRM posted normalized funds from operations per share of $0.48, compared with $0.53 in the previous year quarter. FFO per share reflects a structural tax rate of 23.1% compared with a structural tax rate of 14% in 1Q16. The company reported adjusted FFO of $170.94MM during the quarter compared with $167.57MM in 1Q16.